News

Why B-cell therapies, or why not?

3848 2300 Peter Stevenson, PhD

The rational for B-cell therapy in multiple sclerosis (MS) was presented during ECTRIMS 2019, with David Baker (Blizard Institute, Queen Mary University of London, UK) posing the question of why…

read more

Are stem cells in MS ready for prime time?

2300 1535 Peter Stevenson, PhD

Hot topics continued at ECTRIMS 2019 in Stockholm with Joachim Burman (Department of Neurology, Uppsala University Hospital, Sweden), who stepped up to the podium to discuss autologous haematopoietic stem cell transplantation (aHSCT)…

read more

Enough evidence for vitamin D in MS?

3450 2300 Peter Stevenson, PhD

The role of vitamin D in the treatment of multiple sclerosis (MS) took centre stage during the first day of ECTRIMS 2019 in Stockholm, Sweden. In a ‘Hot Topic’ session,…

read more

Talking to Prof. Claudio Lino Alberto Bassetti

800 534 Rachel Park, MA

Sleep research is one of Prof. Claudio Bassetti’s great passions. He is Head of Department and Senior Consultant at the Department of Neurology, University Hospital of Bern, Switzerland. His research…

read more

Smartphone-controlled device could revolutionise drug delivery in the brain

3450 2300 Peter Stevenson, PhD

A novel brain implant that can deliver drugs and stimulate brain cells could lead to advanced treatments for Parkinson’s, Alzheimer’s, and other brain disorders, a new study reports. The research comes…

read more

Chili proving a hot topic in cognitive decline

3150 2100 Peter Stevenson, PhD

A large study across China has uncovered that eating spicy foods increases the risk of dementia, further calling into question the pertinent links between diet and cognitive function. The China Health and…

read more

“Less is more” in medication-overuse headache

6668 2484 Peter Stevenson, PhD

Monitoring, recognition and effective patient education are cornerstones in the diagnosis and prevention of medication-overuse headache (MOH), delegates heard at the 5th Annual Congress of the European Academy of Neurology…

read more

Treating nature with NURTURE: Interim results of nusinersen for SMA

3473 2300 Mea Holm, PhD

Promising results for a disease-modifying treatment for spinal muscular atrophy (SMA) were presented at the 5th Annual Congress of the European Academy of Neurology (EAN) in Oslo, Norway, last week.…

read more

Natalizumab treatment associated with reduction of gliotic biomarkers in white matter

3067 2300 Michael Furrer, PhD

New data on the effect of natalizumab treatment on neuronal and membrane integrity in lesional white matter were presented at the recent 5th Annual Congress of the European Academy of…

read more

Serum NfL levels shine a light on neuroaxonal damage and disease

4089 2300 Michael Furrer, PhD

The 5th Annual Congress of the European Academy of Neurology (EAN) in Oslo, Norway, featured an in-depth exploration of the role of neurofilament light chain (NfL) protein levels as a…

read more
Brainwork is supported by unrestricted grants from: